JULIE WRIGHT: Open Payments
NPI 1922657147 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,332 in 75 payments from 17 companies in 2025. Trend: 2023 $1,781 · 2024 $1,910 · 2025 $1,332
Food & beverage: $1,332
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $381 |
| PFIZER INC. | 18 | $226 |
| Axsome Therapeutics, Inc. | 4 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $89 |
| Esperion Therapeutics, Inc. | 4 | $67 |
| Antares Pharma, Inc. | 3 | $61 |
| Lilly USA, LLC | 4 | $59 |
| Tandem Diabetes Care, Inc. | 2 | $49 |
| Exact Sciences Corporation | 3 | $48 |
| Amgen Inc. | 2 | $44 |
Products named: VRAYLAR, NURTEC ODT, Auvelity, QULIPTA, TRINTELLIX, NEXLETOL, XYOSTED, UBRELVY.
Industry payments across AL — which companies pay providers there.
